The contribution of medical research towards reducing the impact of bowel cancer cannot be underestimated. Research improves understanding of the disease and drives evidence-based prevention, detection and management strategies.
Supporting medical research is therefore an important aspect of Bowel Cancer Australia's mission.
Bowel Cancer Australia has demonstrated its ongoing commitment to current medical research through annual and specific project grants. These have included:
|Bowel Cancer Research Grant Applications 2013
Bowel Cancer Australia (BCA) is excited to announce that in 2013 we have joined with Federal Government agency, Cancer Australia and other major cancer charities to improve funding for bowel cancer research.
The Priority-driven Collaborative Cancer Research Scheme (PdCCRS) is an annual national research project grants scheme which funds cancer research in identified priority areas to help reduce the impact of cancer in the community and improve outcomes for people affected by cancer.
The call for applications to the Priority-driven Collaborative Cancer Research Scheme for 2013 is now open and closes at 5pm (AEDT) 19 March 2013.
Applicants requesting PdCCRS grant funding from Bowel Cancer Australia are advised that at least one of the following BCA research priorities must be addressed in their application:
Cancer Australia and Bowel Cancer Australia invite applications for Priority-driven Collaborative Cancer Research Grants to commence in 2014.
Bowel Cancer Australia supported project grants are offered in the following PdCCRS category:
Funding Category A: Project grants of up to three years duration, with funding available up to $600,000 (GST-exclusive), with a maximum in any one year of approximately $200,000 (GST-exclusive) will be offered by Bowel Cancer Australia. All project grant applications ranging from 1 to 3 years within a budget ranging from $10,000 to approximately $200,000 per annum will be considered by Cancer Australia and these funding partners.
These research projects must be: